HealthQuill Pharma
AstraZeneca Plc’s investigational drug to treat AL amyloidosis, a rare and serious disease affecting the heart and kidneys, failed to meet its main goal of helping people to live longer.
Drugs Health Pharma

AstraZeneca’s trial drug for AL amyloidosis fails to meet survival goal

HQ Team July 16, 2025: AstraZeneca Plc’s investigational drug to treat AL amyloidosis, a rare and serious disease affecting the heart and kidneys,.

Read More
The US Food and Drug Administration has approved a biosimilar product made by India’s Biocon Biologics Ltd., a subsidiary of Biocon Ltd., to treat diabetes mellitus in adults and pediatric patients.
Drugs Health Pharma

US regulator clears Biocon’s diabetic biosimilar product for Novolog

HQ Team July 15, 2025: The US Food and Drug Administration has approved a biosimilar product made by India’s Biocon Biologics Ltd., a.

Read More
ViiV Healthcare, majority owned by GSK, has signed a pact with the UN-backed Medicines Patent Pool (MPP) to enable generic access to its HIV treatment in 133 countries.
Drugs Health Pharma

ViiV to grant generic access to its HIV medicine to benefit 133 nations

HQ Team July 15, 2025: ViiV Healthcare, majority owned by GSK, has signed a pact with the UN-backed Medicines Patent Pool (MPP) to.

Read More
Global infant vaccination rates were up marginally last year, but shortfalls in funding, instability, and rising misinformation threaten to block further progress, the UNICEF stated.
Drugs Health Pharma

Funding shortage, conflicts hinder infant vaccination progress: UNICEF

HQ Team July 15, 2025: Global infant vaccination rates were up marginally last year, but shortfalls in funding, instability, and rising misinformation threaten.

Read More
A patient in Northern Arizona, US, has died from pneumonic plague, the first such death in the country since 2007, according to a government statement.
Drugs Health Pharma

Northern Arizona resident dies of pneumonic plague, first since 2007

HQ Team July 13, 2025: A patient in Northern Arizona, US, has died from pneumonic plague, the first such death in the country.

Read More
AbbVie Inc. and IGI Therapeutics SA have signed a $2 billion licensing agreement that gives AbbVie access to an antibody being tested for certain types of cancers and autoimmune conditions.
Drugs Health Pharma

AbbVie inks $2 billion deal with IGI, bags antibody to fight cancer 

HQ Team July 10, 2025: AbbVie Inc. and IGI Therapeutics SA have signed a $2 billion licensing agreement that gives AbbVie access to.

Read More
Gilead Sciences Inc. and the Global Fund have signed a pact to supply an HIV prevention drug at no profit to benefit two million people in low-income nations.
Drugs Health Pharma

Gilead, Global Fund to supply HIV prevention drug to two million people

HQ Team July 10, 2025: Gilead Sciences Inc. and the Global Fund have signed a pact to supply an HIV prevention drug at.

Read More
The US drug regulator has urged industry leaders manufacturing and distributing foods for infants and children to be radically transparent in product recall communications.
Drugs Health Pharma

FDA calls on infant foodmakers to be transparent on product recalls

HQ Team July 10, 2025: The US drug regulator has urged industry leaders manufacturing and distributing foods for infants and children to be.

Read More
The US drug regulator has approved changes in the prescription of Eli Lilly’s drug Kisunla for treating adults with early Alzheimer’s disease, including those with mild memory problems or mild dementia.
Drugs Health Pharma

FDA permits slow dosing of Eli Lilly’s Alzheimer’s drug Kisunla

HQ Team July 9, 2025: The US drug regulator has approved changes in the prescription of Eli Lilly’s drug Kisunla for treating adults.

Read More
Merck & Co. will acquire UK-based Verona Pharma Plc for about $10 billion to gain access to a respiratory drug approved by the US regulator, according to a statement from Merck.
Drugs Health Pharma

Merck to acquire Verona Pharma for $10 billion to net respiratory drug 

HQ Team July 9, 2025: Merck & Co. will acquire UK-based Verona Pharma Plc for about $10 billion and gain access to a.

Read More